This unique opportunity will allow the Company to expand its research on its osteoconductive bone adhesive biomaterial.
LOWELL, Mass., March 9, 2021 (RevBio PR) — RevBio, Inc., announced that it has been awarded the opportunity to conduct an in vivo research experiment on the International Space Station U.S. National Laboratory (ISS National Lab). This experiment will examine the biomaterial’s osteoconductivity when used in a microgravity environment where bone density and the ability to regenerate new bone tissue is significantly compromised.(more…)
- Parabolic Arc
- March 12, 2021